# LACOSAMIDE
> **ANDA220268** · Abbreviated New Drug Application (Generic) · Sponsor: GLENMARK PHARMS · Approved 2026-01-21
## Drug
- **FDA Application Number:** ANDA220268
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LACOSAMIDE
- **Generic name:** LACOSAMIDE
- **Active ingredients:** LACOSAMIDE
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** GLENMARK PHARMS
- **Manufacturer:** GLENMARK PHARMACEUTICALS INC., USA
- **First approval:** 2026-01-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220268)
---
*MORVS · CC0 1.0*